Search Results
Overview
| Uniprot ID | P40925 |
|---|---|
| Protein Name | Malate dehydrogenase, cytoplasmic |
| Gene Name | MDH1 |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position | Flanking peptide |
|---|---|
| 103 | MERKDLLKANVKIFK |
| 107 | DLLKANVKIFKSQGA |
| 110 | KANVKIFKSQGAALD |
| 118 | SQGAALDKYAKKSVK |
| 125 | KYAKKSVKVIVVGNP |
| 142 | TNCLTASKSAPSIPK |
| 149 | KSAPSIPKENFSCLT |
| 164 | RLDHNRAKAQIALKL |
| 170 | AKAQIALKLGVTAND |
| 199 | YPDVNHAKVKLQGKE |
| 205 | AKVKLQGKEVGVYEA |
| 214 | VGVYEALKDDSWLKG |
| 236 | QRGAAVIKARKLSSA |
| 239 | AAVIKARKLSSAMSA |
| 248 | SSAMSAAKAICDHVR |
| 312 | INDFSREKMDLTAKE |
| 318 | EKMDLTAKELTEEKE |
| 73 | KDVIATDKEDVAFKD |
Function
Catalyzes the reduction of aromatic alpha-keto acids in the presence of NADH (PubMed:2449162, PubMed:3052244). Plays essential roles in the malate-aspartate shuttle and the tricarboxylic acid cycle, important in mitochondrial NADH supply for oxidative phosphorylation (PubMed:31538237). Catalyzes the reduction of 2-oxoglutarate to 2-hydroxyglutarate, leading to elevated reactive oxygen species (ROS) (PubMed:34012073)
Protein Sequence
Gene Ontology
| Classification | GO ID | Description |
|---|---|---|
| Cellular Component | GO:0005737 | cytoplasm |
| Cellular Component | GO:0005829 | cytosol |
| Cellular Component | GO:0070062 | extracellular exosome |
| Cellular Component | GO:0005615 | extracellular space |
| Molecular Function | GO:0047995 | (2R)-hydroxyphenylpyruvate reductase [NAD(P)H] activity |
| Molecular Function | GO:0030060 | L-malate dehydrogenase (NAD+) activity |
| Molecular Function | GO:0004470 | malic enzyme activity |
| Biological Process | GO:0006108 | malate metabolic process |
| Biological Process | GO:0043490 | malate-aspartate shuttle |
| Biological Process | GO:0019674 | NAD+ metabolic process |
| Biological Process | GO:0006739 | NADP+ metabolic process |
| Biological Process | GO:0006107 | oxaloacetate metabolic process |
| Biological Process | GO:0006099 | tricarboxylic acid cycle |
Reference
[1] Yang D, Yin J, Shan L, Yi X, Zhang W et al.. Identification of lysine-lactylated substrates in gastric cancer cells.. iScience 25(7):104630. 2022 Jul 15. PMID: 35800753.
[2] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.
[3] Hong H, Chen X, Wang H, Gu X, Yuan Y et al.. Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma.. Proteomics 23(9):e2200432. 2023 May. PMID: 36625413.
[4] Shi CM, Wang QC, Li XL, Yang YH, Tang XY et al.. Global Profiling of Protein Lactylation in Human Hippocampi.. Proteomics Clin Appl 19(2):e202400061. 2025 Mar. PMID: 39610256.
[5] He J, Lai T, Zhou Z, Yang H, Lei Z et al.. Multiomics profiling reveals the involvement of protein lactylation in nonhomologous end joining pathway conferring radioresistance in lung adenocarcinoma cell.. Sci Rep 15(1):24651. 2025 Jul 9. PMID: 40634431.
[6] Wu Q, Li Z, Gong T, Zheng X, Zhou X et al.. Porphyromonas gingivalis infection induces lysine lactylation reprogramming in human umbilical vein endothelial cells.. Front Cell Infect Microbiol 16:1706727. 2026. PMID: 41696360.